Daré Bioscience, Inc.
DARE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $26,786 | $21,202 | $25,314 | $26,511 |
| - Cash | $23,075 | $5,035 | $10,330 | $15,698 |
| + Debt | $2,933 | $3,033 | $8,314 | $1,303 |
| Enterprise Value | $6,643 | $19,200 | $23,298 | $12,115 |
| Revenue | $2 | -$21 | $25 | -$64 |
| % Growth | 110.7% | -183.3% | 140% | – |
| Gross Profit | -$611 | -$21 | -$2,272 | -$14,286 |
| % Margin | -26,993.9% | 100% | -8,935.2% | 22,446% |
| EBITDA | -$2,737 | -$3,368 | -$4,423 | -$5,382 |
| % Margin | -120,987.2% | 15,906.5% | -17,394.9% | 8,455.7% |
| Net Income | -$3,563 | -$4,016 | -$4,378 | -$5,506 |
| % Margin | -157,505.1% | 18,970.7% | -17,219.1% | 8,651.5% |
| EPS Diluted | -0.279 | -0.45 | -0.5 | -0.65 |
| % Growth | 37.9% | 10% | 23.1% | – |
| Operating Cash Flow | -$442 | -$5,417 | -$5,471 | $5,227 |
| Capital Expenditures | -$175 | $153 | -$157 | -$563 |
| Free Cash Flow | -$617 | -$5,264 | -$5,628 | $4,664 |